Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “End-of-Life”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07252739
What this trial is testing

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 140
Not applicableLooking for participantsNCT06739239
What this trial is testing

French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR

Who this might be right for
Defibrillators, ImplantableSudden Cardiac Death Due to Cardiac Arrhythmia
Paris Sudden Death Expertise Center 1,000
Not applicableWithdrawnNCT02253667
What this trial is testing

Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients

Who this might be right for
Lung DiseaseAcute Respiratory Distress Syndrome
Hospital Sao Joao
Testing effectiveness (Phase 2)Study completedNCT04305041
What this trial is testing

Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 100
Not applicableNot Yet RecruitingNCT07486154
What this trial is testing

Complex Decisions Regarding Antithrombotic Therapy: the QUIET Study

Who this might be right for
Palliative Care
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Large-scale testing (Phase 3)Study completedNCT00000480
What this trial is testing

Multicenter Unsustained Tachycardia Trial (MUSTT)

Who this might be right for
ArrhythmiaCardiovascular DiseasesCoronary Disease+4 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT01262508
What this trial is testing

Development of Algorithms to Predict Hemodynamic Instability

Who this might be right for
Sudden Cardiac Death
Klinik für Kardiologie, Pneumologie und Angiologie 60
Not applicableStudy completedNCT04330833
What this trial is testing

Informational Meetings for Planning and Coordinating Treatment

Who this might be right for
End of LifeCommunicationCancer Metastatic
Indiana University 111
Not applicableStudy completedNCT03411018
What this trial is testing

Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia

Who this might be right for
Bronchopulmonary Dysplasia
Manuel Sanchez Luna 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT05557591
What this trial is testing

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals 51
Large-scale testing (Phase 3)Study completedNCT00671060
What this trial is testing

Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy

Who this might be right for
Intrauterine Fetal Demise
Gynuity Health Projects 153
Not applicableStudy completedNCT01632774
What this trial is testing

Analysis of Risk Factors for Death After Blunt Traumatic Rupture of the Thoracic Aorta

Who this might be right for
Aortic Rupture
University of Zurich 85
Not applicableUnknownNCT05418660
What this trial is testing

Observational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer
University of Milano Bicocca 300
Post-approval studies (Phase 4)Ended earlyNCT02034279
What this trial is testing

The INFECIR-2 Albumin Prevention Study

Who this might be right for
Advanced Chronic Liver DiseaseUrinary InfectionPneumonia+2 more
EASL - CLIF Consortium 136
Large-scale testing (Phase 3)Study completedNCT04509674
What this trial is testing

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

Who this might be right for
Myocardial Infarction
Boehringer Ingelheim 6,522
Not applicableEnded earlyNCT00524862
What this trial is testing

Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death

Who this might be right for
Coronary Heart DiseaseCongestive Heart FailureVentricular Dysfunction+2 more
Unity Health Toronto 5,000
Not applicableStudy completedNCT00675246
What this trial is testing

Antenatal Corticoid Therapy for Late Preterm Babies

Who this might be right for
Hyaline Membrane DiseaseTransient Tachypnea
Instituto Materno Infantil Prof. Fernando Figueira 320
Not applicableNot Yet RecruitingNCT07415642
What this trial is testing

Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)

Who this might be right for
Sudden Cardiac Death
University Medical Center Groningen 720
Not applicableStudy completedNCT06948669
What this trial is testing

Brain Death and Organ Donation in Tunisian Intensive Care Units

Who this might be right for
Brain InjuryComaOrgan Transplants
Faculty of Medicine, Sousse 104
Not applicableLooking for participantsNCT04778761
What this trial is testing

ACP Video Intervention for Patients With Life-Limiting Illness

Who this might be right for
Health Care UtilizationEnd Stage Disease
Massachusetts General Hospital 500
Next Page